MOR1 receptor mRNA expression in human brains of drug-related fatalities - A real-time PCR quantification

Forensic Science International

Volumn 140, Issue 1, 2004, Pages 13-20

  Becker, J ^a   Schmidt, P ^a   Musshoff, F ^a   Fitzenreiter, M ^a   Madea, B ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Addiction; Human brain; mRNA quantification; Real time PCR; Opiate receptor (MOR1)

Indexed keywords

MESSENGER RNA; MU OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; CAUSE OF DEATH; CHRONIC DRUG ADMINISTRATION; FATALITY; FRONTAL CORTEX; HAIR ANALYSIS; HIPPOCAMPUS; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; INTOXICATION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SUBSTANCE ABUSE; THALAMUS; VENTRAL TEGMENTUM;

EID: 0842348090     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2003.10.012     Document Type: Article

References (34)

1. Kreek M.J. Opiates, opioids and addiction. Mol. Psychiatry. 1:1996;232-254.
2. Kreek M.J. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem. Res. 21:1996;1469-1488.
3. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20:1999;19-26.
4. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
5. Hiller J.H., Fan L.-Q. Laminar distribution of the multiple opioid receptors in the human cerebral cortex. Neurochem. Res. 21:1996;1333-1345.
6. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A.H., Dado R.J., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
7. Schmidt P., Schmolke C., Musshoff F., Prohaska C., Menzen M., Madea B. Numerical density of μ-opioid receptor expressing neurons in the frontal cortex of drug related fatalities. Forensic Sci. Int. 115:2001;219-229.
8. 33P in situ hybridization study Neuroscience. 88:1999;1093-1135.
9. Harrison L.M., Kastin A.J., Zadina J.E. Opiate tolerance and dependence: receptors, G-proteins and antiopiates. Peptides. 19:1998;1603-1630.
10. Escriba P.V., Sastre M., Garcia-Sevilla J.A. Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts. Arch. Gen. Psychiatry. 51:1994;494-501.
11. Garcia-Sevilla J.A., Ventayol P., Busquets X., La Harpe R., Walzer C., Guimón J. Regulation of immunolabelled mu-opioid receptors and protein kinase C-α and isoforms in the frontal cortex of human opiate addicts. Neurosci. Lett. 226:1997;29-32.
12. Busquets X., Escriba P.V., Sastre M., Garcia-Sevilla J.A. Loss of protein kinase C-alpha beta in brain of heroin addicts and morphine-dependent rats. J. Neurochem. 64:1995;247-252.
13. Werling L.L., McMahon P.N., Cox B.M. Selective changes in mu-opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. U.S.A. 86:1989;6393-6397.
14. Puttfarcken P.S., Cox B.M. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45:1989;1937-1942.
15. Pert C.B., Snyder S.H. Opiate receptor binding-enhancement by opiate administration in vivo. Biochem. Pharmacol. 25:1976;847-853.
16. 3H ] cycloFOXY: a novel opiate antagonist suitable for positron emission tomography Eur. J. Pharmacol. 142:1987;73-81.
17. 5]enkephalin: further evidence for two mu-binding sites Eur. J. Pharmacol. 160:1989;71-82.
18. Brady L.S., Herkenham M., Long J.B., Rothman R.B. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitiative autoradiographic study. Brain Res. 477:1989;382-386.
19. Bolger G.T., Skolnick P., Rice K.C., Weissmann B.A. Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats. FEBS Lett. 234:1988;22-26.
20. 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts. Psychopharmacology. 115:1994;135-140.
21. P. Schmidt, C. Schmolke, F. Musshoff, M. Menzen, C. Prohaska, B. Madea, Area-specific increased density of μ opioid receptor immunoreactive neurons in the cerebral cortex of drug-related fatalities, Forensic Sci. Int. 133 (2003) 204-211.
22. Buzas B., Rosenberger J., Cox B.M. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. NeuroReport. 7:1996;1505-1508.
23. Brodsky M., Elliot K., Hynansky A., Inturrisi C.E. CNS levels of μ-opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res. Bull. 38:1995;135-141.
24. Castelli M.P., Melis M., Mameli M., Fadda P., Diaz G., Gessa G.L. Chronic morphine and naltrexone fail to modify μ-opioid receptor mRNA levels in the rat brain. Mol. Brain Res. 45:1997;149-153.
25. Leonard S., Logel J., Luthman D., Casanova M., Kirch D., Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol. Psychiatry. 33:1993;455-456.
26. Harrison P.J., Burnet P.W., Falkai P., Bogerts B., Eastwood S.L. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex. Schizophr. Res. 26:1997;93-102.
27. Schramm M., Falkai P., Tepest R., Schneider-Axmann T., Przkora R., Waha A., Pietsch T., Bonte W., Bayer T.A. Stability of RNA transcripts in post-mortem psychiatric brains. J. Neural. Transm. 106:1999;329-335.
28. Castensson A., Emilsson L., Preece P., Jazin E.E. High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10:2000;1219-1229.
29. Waha A., Watzka M., Koch A., Pietsch T., Przkora R., Peters N., Wiestler O.D., Deimling A.V. A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol. 8:1998;13-18.
30. Koob G.F. Drugs of abuse "anatomy" pharmacology and function of reward pathways. TIPS. 13:1992;177-184.
31. U. Bonnet, M. Gastpar, Opioide, in: M. Gastpar, K. Mann, H. Rommelspacker (Eds.), Lehrbuch der Suchterkrankungen, Thieme, Stuttgart, New York, 1999, pp. 237-262.
32. Wang X.-M., Zhou Y., Spangler R., Ho A., Han J.-S., Kreek M.J. Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain. Mol. Brain Res. 66:1999;184-187.
33. Jenab S., Inturrisi C.E. Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cells. Mol. Brain Res. 27:1994;95-102.
34. Sehba F., Duttaroy A., Shah S., Chen B., Carroll J., Yoburn B.C. In vivo homologous regulation of μ-opioid receptor gene expression in the mouse. Eur. J. Pharmacol. 339:1997;33-41.